Search
Codexis Inc
CDXSAdd to Watchlist
1.560USD
-0.040-2.50%
Close 08-14 16:00（ET）Quotes delayed by 15 min
170.83MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of Codexis Inc is 8.00, ranking 170 out of 387 in the Biotechnology & Medical Research industry. The average price target is 7.00, with a high of 11.00 and a low of 2.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
6.500
Target Price
+316.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Codexis Inc
CDXS
7
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Codexis Inc's expected revenue for the next quarter?
Codexis Inc's expected revenue is 17.94M.
What is Codexis Inc's price target?
Analysts forecast that Codexis Inc's price target is USD 7.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.00.
How have Codexis IncCDXS's recent earnings per share performed?
The market expectation was USD -0.13, while Codexis IncCDXS's earnings per share (EPS) for the previous quarter was USD -0.10. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for Codexis Inc?
Based on the ratings of Codexis Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.